Recruiting the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer NCT07380646 Conditions Agranulocytosis, Breast Cancer, Breast Diseases, +14 more Locations Breast surgery department — Hangzhou, Zhejiang, China View Trial Details
Recruiting Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study NCT06805812 Conditions Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more Locations Centro di Riferimento Oncologico IRCCS — Aviano, Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili — Brescia, Italy Humanitas Istituto Clinico Catanese — Catania, Italy ASST Lariana - Ospedale Sant'Anna — Como, Italy View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence. NCT07443774 Conditions Abemaciclib, Breast Cancer, Breast Diseases, +9 more Locations CHU Grenoble Alpes — Grenoble, France View Trial Details
Completed A Deep Learning Method to Evaluate QT on Ribociclib NCT05623397 Conditions Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more Locations Groupe Ambroise Paré, Hartmann — Neuilly-sur-Seine, France Hôpital Tenon — Paris, France CIC - Hôpitaux Universitaires Pitié Salpêtrière, Paris, FRANCE — Paris, France Institut Gustave Roussy — Villejuif, France View Trial Details
